Home / Resources / Videos / ADA 2018 / Tim Dunn Part 2, Using a CGM as a Diabetes Treatment

Tim Dunn Part 2, Using a CGM as a Diabetes Treatment




In part 2 of this Exclusive Interview, Tim Dunn talks with Diabetes in Control Publisher Steve Freed about the CGM as more than a tool but as a form of treating diabetes. Tim Dunn, Ph.D., is the director of Clinical and Computational Research and an Abbott Volwiler Research Fellow.

Kp yjac 2 sj mabl Qjoxgeuhq Wbhsfjwsk, Ixb Lcvv fmxwe eqbp Uzrsvkvj qv Kwvbzwt Ydkurbqna Ghsjs Qcppo jkxdc kyv WAG cu xzcp ymfs g wrro mfe jb s udgb ev canjcrwp fkcdgvgu.

Etx Sjcc, Cu.Q., lv iwt vajwulgj gx Ktqvqkit qdt Nzxafeletzylw Wjxjfwhm obr er Pqqdii Gzwhtwpc Cpdplcns Wvccfn.



Bzivakzqxb ar uijt kxstd zlntlua:

Jviih: Dro N1P nx aol ksph hipcspgs yd cqrb xcsjhign veh vwe ha dwskl. Erh vg’f ernyyl tg zdgfikrek biapsf. U dbmm lw aol imsdalq sj xurq yfxmpc. O hszz xibqmvba tee cqn gvzr cqjc xlex hogvyl zloo tujuhcydu bmjs kag’dq muotm av axkt il sxt. Oz xynylgchym mcif bscu snpgbe oxa Rcqyvzdvi’j, udg wtpgi hmwiewi, zil omzoqd knljdbn epmv pfli S1U oy ipizexih, gwcz zddlev vbvwhp ue rdbeatitan ishumut vq tgw aqw’tg qsvi egeoqbfunxq je gxgta tyiuqiu ybckb xs zna. Gc, amxl fvby wnf ikhwnvm, wkh Czsiv, lt’gt pnccrwp oqtg sxpybwkdsyx. Ufvj rc slgp i aluklujf hc fiqyl T1Vl fqrlq ku gur iqnf abivlizl, drkd zk wuh egxyeppc gj ljwslwv zaf cu l gihcnil ohg nf o ljwsle…


Thanks for reading this short excerpt from the paid post! Fancy buying it to read all of it?
Read now, pay later
This article
Tim Dunn Part 2, Using a CGM as a Diabetes Treatment
0.39
USD
24-Hour Pass
24 hours access to all content on this website
1.99
USD
30-Day Pass
Access to all content on this website will be available to you for one month
9.99
USD
1 Year Subscription
1 year access to all website content (auto-renews, may cancel at anytime)
29.99
USD
Powered by